BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang D, Zhang H, Xiang T, Wang G. Clinical Application of Adaptive Immune Therapy in MSS Colorectal Cancer Patients. Front Immunol 2021;12:762341. [PMID: 34721435 DOI: 10.3389/fimmu.2021.762341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ghazi B, El Ghanmi A, Kandoussi S, Ghouzlani A, Badou A. CAR T-cells for colorectal cancer immunotherapy: Ready to go? Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.978195] [Reference Citation Analysis]
2 Yuan J, Li J, Gao C, Jiang C, Xiang Z, Wu J. Immunotherapies catering to the unmet medical need of cold colorectal cancer. Front Immunol 2022;13:1022190. [DOI: 10.3389/fimmu.2022.1022190] [Reference Citation Analysis]
3 Komatsu Y, Shigeyasu K, Yano S, Takeda S, Takahashi K, Hata N, Umeda H, Yoshida K, Mori Y, Yasui K, Yoshida R, Kondo Y, Kishimoto H, Teraishi F, Umeda Y, Kagawa S, Michiue H, Tazawa H, Goel A, Fujiwara T. RNA editing facilitates the enhanced production of neoantigens during the simultaneous administration of oxaliplatin and radiotherapy in colorectal cancer. Sci Rep 2022;12:13540. [PMID: 35941214 DOI: 10.1038/s41598-022-17773-0] [Reference Citation Analysis]
4 Liu XY, Zhang B, Cheng YX, Tao W, Yuan C, Wei ZQ, Peng D. Does chronic kidney disease affect the complications and prognosis of patients after primary colorectal cancer surgery? World J Gastrointest Oncol 2022; 14(6): 1199-1209 [DOI: 10.4251/wjgo.v14.i6.1199] [Reference Citation Analysis]